Pharmafile Logo
Pharmafocus logo
Advanced Search
abbvie image

CLL drug achieves ‘unprecedented’ remissions

December 9, 2013
Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199

AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …

News
sovaldi image

Gilead’s $1,000 per day Hep C drug approved

December 9, 2013
Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi

Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …

News

API imports in the EU: gauging the FMD’s impact

December 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing API, EMA, FMD, Taylor, manufacturing, supply chain

The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …

Feature
yuri_pikover_savara

Savara Pharmaceuticals appoints two board members

December 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph McCracken, Pikover, savara

Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …

Appointment
iclusig image

EMA in new Iclusig probe

December 9, 2013
Sales and Marketing Ariad, EMA, iclusig, leukaemia

Europe’s medicines regulator has begun a new review of Ariad Pharmaceuticals’ leukaemia drug Iclusig, looking in particular at the risk …

News
gsk image

GSK launches cancer ‘consortium’

December 6, 2013
Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research

GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …

News
jerrytolk_fleishmanhillard

FleishmanHillard hires senior head from Edelman

December 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FleishmanHillard, tolk

Comms and PR global agency FleishmanHillard has appointed Jerry Tolk to be its senior VP, partner and general manager in …

Appointment
NICE image

NICE wants more Lemtrada data

December 6, 2013
Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …

News
EMA image

Court annuls EMA data decision

December 5, 2013
Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency

The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …

News
Sanofi image

New insulin scores for Sanofi

December 5, 2013
Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300

Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …

News

UPDATED: Pfizer first on trial transparency

December 5, 2013
Medical Communications, Sales and Marketing EMA, Goldacre, Pfizer, alltrials, transparency

News
richard_evens_bsc

British Safety Council appoints new commercial director

December 5, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BSC, richard evens

Not-for-profit organisation The British Safety Council has appointed Richard Evens as its new commercial director. Evens will be responsible for …

Appointment

Astellas seeks Xtandi extension

December 5, 2013
Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi

Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …

News
Jonathan Emms

Pfizer head to be ABPI president

December 4, 2013
Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna

The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …

News
Pfizer image

Pfizer expands in Poland

December 4, 2013
Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma

Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …

News
Forest labs image

Forest cuts jobs in restructure

December 4, 2013
Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts

Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …

News
David Cameron image

Prime minister backs GSK in corruption row

December 4, 2013
Medical Communications, Sales and Marketing China, GSK, bribery, david cameron

Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …

News
catherine_barnett

Just:: Health hires new director from Edelman

December 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Just: Health, Just:: Health

Just:: Health Communications has hired Catherine Barnett to strengthen its senior management team from January next year.  Barnett is currently …

Appointment
Celgene image

Celgene signs $177 million OncoMed deal

December 4, 2013
Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell

Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …

News
research image

Report: ‘R&D isn’t paying’

December 3, 2013
Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters

On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026